Randomized controlled study to evaluate the impact of flexible patient-controlled visits in people with type 1 diabetes: The DiabetesFlex Trial.
Tinne LaurbergLiv Marit Valen SchougaardNiels Henrik Ingvar HjollundKirsten Elisabeth LomborgTroels Krarup HansenAnnesofie Lunde JensenPublished in: Diabetic medicine : a journal of the British Diabetic Association (2022)
Compared with standard care, flexible patient-controlled visits combined with patient-reported outcomes in participants with metabolic controlled type 1 diabetes and good psychological well-being further improved diabetes-related well-being and decreased face-to-face visits while maintaining safe diabetes management.
Keyphrases
- type diabetes
- patient reported outcomes
- glycemic control
- cardiovascular disease
- phase iii
- case report
- phase ii
- open label
- healthcare
- clinical trial
- double blind
- study protocol
- insulin resistance
- quality improvement
- placebo controlled
- weight loss
- adipose tissue
- physical activity
- health insurance
- solid state
- drug induced